Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
Crossref DOI link: https://doi.org/10.1007/s00198-014-2964-2
Published Online: 2014-11-18
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sugimoto, T.
Matsumoto, T.
Hosoi, T.
Miki, T.
Gorai, I.
Yoshikawa, H.
Tanaka, Y.
Tanaka, S.
Fukunaga, M.
Sone, T.
Nakano, T.
Ito, M.
Matsui, S.
Yoneda, T.
Takami, H.
Watanabe, K.
Osakabe, T.
Okubo, N.
Shiraki, M.
Nakamura, T.
Text and Data Mining valid from 2014-11-18